Men's Health News

RSS

The growing evidence on standardised packaging of tobacco products

The scientific journal Addiction has today published a collection of peer-reviewed research papers and commentaries that bring together key parts of the evidence base for standardised packaging of tobacco products from 2008 to 2015.

17 Feb 2015

Cabazitaxel therapy may be more effective in treating prostate cancer

Prostate cancer is the second leading cause of cancer for men in the United States. Only one class of chemotherapy called taxanes is effective against the disease.

17 Feb 2015

Microsurgical technique revolutionizes treatment of infertile men

A microsurgical technique credited with revolutionizing treatment of men once thought to be infertile was recently performed at Henry Ford Hospital in Detroit, a first for southeast Michigan.

17 Feb 2015

Breath test could detect Parkinson’s

The researchers, with funding from Parkinson’s UK and the British Council, will study around 200 people and see if just by looking at their breath they can determine which have Parkinson’s.

16 Feb 2015

Unemployment linked with around 45 000 deaths by suicide every year

These striking findings suggest that suicide prevention strategies need to target the negative health effects of unemployment in times of economic stability as well as during recession.

16 Feb 2015

Experts question value of current obesity treatments

Many people with obesity can lose weight for a few months, but 80%–95% regain their lost weight eventually. One explanation for this limited long-term success is that reducing caloric intake triggers several biological systems that drive us to eat high-calorie foods and gain weight.

16 Feb 2015

FOI Request by Bowel Cancer UK highlights big variation in tests for lynch syndrome

Bowel Cancer UK submitted the FOI request in November 2014 to every NHS trust in England, health board in Scotland and health and social care trust in Northern Ireland to establish the number of trusts/health boards which were implementing the testing for all bowel cancer patients under 50, as mandated by the Royal College of Pathologists. Lynch syndrome is responsible for around one in 12 cases of bowel cancer in people aged under 50.

16 Feb 2015

Changes in moles and skin cancer: an interview with Dr Anjali Mahto, Consultant Dermatologist & British Skin Foundation Spokesperson

Melanoma is the 5th most common cancer in the UK and its incidence is continuing to increase since the mid-1970s. Cancer Research UK reports that its rates have increased more rapidly than any of the current ten most common cancers in males and females. Whilst some of this may be attributed to better surveillance and earlier detection, the real problem lies with sun-seeking behaviour and exposure to ultraviolet (UV) radiation.

16 Feb 2015

Research finding could lead to new therapeutic target for treating hypertension in males

Higher levels of a "danger" molecule may be one reason males tend to become hypertensive earlier and more severely than females, scientists say.

16 Feb 2015

Scientists find seven new genes that can cause X-linked intellectual disability

X-linked intellectual disability is a disorder that predominantly affects men and can have highly variable clinical manifestations. Scientists at the Max Planck Institute for Molecular Genetics in Berlin have found seven new genes that can cause this genetic disease: Mutations of these genes on the X chromosome lead to various forms of intellectual disability.

15 Feb 2015

GenomeDx announces publication of positive validation study for Decipher Prostate Cancer Classifier

GenomeDx Biosciences today announced the publication of a positive validation study for the Decipher® Prostate Cancer Classifier, a genomic test for prostate cancer. The study, published in the Journal of Clinical Oncology, showed that patients with low genomic risk (as determined by Decipher) may be optimally managed with observation after radical prostatectomy (prostate surgery), while those with high genomic risk (as determined by Decipher) may be better managed earlier with adjuvant radiotherapy.

10 Feb 2015

Biocartis to develop Rapid Ebola Virus Triage Test

Biocartis believes its Rapid Ebola Virus Triage Test could provide a sustainable solution for rapid detection of Ebola-infected patients even after the current Ebola outbreak.

10 Feb 2015

Griffith research unlocks more about cancer

A research collaboration between Griffith and the Malaghan Institute in Wellington, New Zealand has made the discovery that mitochondria are capable of passing through the healthy membrane of a host cell into defective tumour cells, possibly kicking off the rapid proliferation of tumour cells which is the hallmark of cancer.

10 Feb 2015

‘Fear of bad news’ prevents 1 in 5 Brits from having a health check

There is no doubt that awaiting the results from medical tests can be an anxious time for anyone. However new research revealed today by HeartAge has revealed that when it comes to undertaking a general health check, almost 1 in 5 Brits appear to be opting for the “burying heads in the sand” approach, with`19% stating that concern over test results would prevent them from having a health check.

9 Feb 2015

Abiraterone drug improves survival in prostate cancer patients when given before chemotherapy

Pioneering prostate cancer drug abiraterone significantly extends the lives of men with advanced prostate cancer if given before chemotherapy, the results of a major phase III clinical trial have shown.

9 Feb 2015

Prostate cancer patients with detectable post-operative PSA should receive more aggressive treatment

Prostate cancer patients with detectable prostate specific antigen (PSA) following radical prostatectomy should receive earlier, more aggressive radiation therapy treatment, according to a study published in the February 1, 2015 issue of the International Journal of Radiation Oncology * Biology * Physics (Red Journal), the official scientific journal of the American Society for Radiation Oncology.

6 Feb 2015

Researchers develop optimised PSA screening programme for prostate cancer

As an indicator of prostate cancer, the PSA test is regarded in urology as highly controversial since it is not always unequivocal. A team of researchers from the Comprehensive Cancer Center at the MedUni Vienna and Vienna General Hospital has now developed a programme that compensates the shortfalls of PSA screening with methods from personalised medicine. As a result, prostate cancer screening is able to reach a new level of quality.

4 Feb 2015

Study: Targeted biopsy technique better than standard biopsy at detecting high-risk prostate cancer

Among men undergoing biopsy for suspected prostate cancer, targeted magnetic resonance/ultrasound fusion biopsy, compared with a standard biopsy technique, was associated with increased detection of high-risk prostate cancer and decreased detection of low-risk prostate cancer, according to a study in the January 27 issue of JAMA.

28 Jan 2015

Androgen receptor in prostate cancer cells can activate different gene set when bound to antiandrogens

The androgen receptor in prostate cancer cells can activate different sets of genes depending on whether it binds with an androgen hormone or an antiandrogen drug, according to a new study led by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.

28 Jan 2015

Purdue University researchers find promising way to treat late-stage prostate cancer

Low doses of metformin, a widely used diabetes medication, and a gene inhibitor known as BI2536 can successfully halt the growth of late-stage prostate cancer tumors, a Purdue University study finds.

28 Jan 2015

Men's Health News

The growing evidence on standardised packaging of tobacco products

Cabazitaxel therapy may be more effective in treating prostate cancer

Microsurgical technique revolutionizes treatment of infertile men

Breath test could detect Parkinson’s

Unemployment linked with around 45 000 deaths by suicide every year

Experts question value of current obesity treatments

FOI Request by Bowel Cancer UK highlights big variation in tests for lynch syndrome

Changes in moles and skin cancer: an interview with Dr Anjali Mahto, Consultant Dermatologist & British Skin Foundation Spokesperson

Research finding could lead to new therapeutic target for treating hypertension in males

Scientists find seven new genes that can cause X-linked intellectual disability

GenomeDx announces publication of positive validation study for Decipher Prostate Cancer Classifier

Biocartis to develop Rapid Ebola Virus Triage Test

Griffith research unlocks more about cancer

‘Fear of bad news’ prevents 1 in 5 Brits from having a health check

Abiraterone drug improves survival in prostate cancer patients when given before chemotherapy

Prostate cancer patients with detectable post-operative PSA should receive more aggressive treatment

Researchers develop optimised PSA screening programme for prostate cancer

Study: Targeted biopsy technique better than standard biopsy at detecting high-risk prostate cancer

Androgen receptor in prostate cancer cells can activate different gene set when bound to antiandrogens

Purdue University researchers find promising way to treat late-stage prostate cancer

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News